These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27251038)

  • 1. A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker.
    Garrigou S; Perkins G; Garlan F; Normand C; Didelot A; Le Corre D; Peyvandi S; Mulot C; Niarra R; Aucouturier P; Chatellier G; Nizard P; Perez-Toralla K; Zonta E; Charpy C; Pujals A; Barau C; Bouché O; Emile JF; Pezet D; Bibeau F; Hutchison JB; Link DR; Zaanan A; Laurent-Puig P; Sobhani I; Taly V
    Clin Chem; 2016 Aug; 62(8):1129-39. PubMed ID: 27251038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of specific hypermethylated WIF1 and NPY genes in circulating DNA by crystal digital PCR™ is a powerful new tool for colorectal cancer diagnosis and screening.
    Overs A; Flammang M; Hervouet E; Bermont L; Pretet JL; Christophe B; Selmani Z
    BMC Cancer; 2021 Oct; 21(1):1092. PubMed ID: 34627187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer.
    Moati E; Blons H; Taly V; Garlan F; Wang-Renault SF; Pietrasz D; Didelot A; Garrigou S; Saint A; Pernot S; Taieb J; Laurent-Puig P; Zaanan A
    Int J Cancer; 2020 Aug; 147(4):1185-1189. PubMed ID: 31472013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.
    Zhou J; Chang L; Guan Y; Yang L; Xia X; Cui L; Yi X; Lin G
    PLoS One; 2016; 11(7):e0159708. PubMed ID: 27459628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
    Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
    BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
    Sato KA; Hachiya T; Iwaya T; Kume K; Matsuo T; Kawasaki K; Abiko Y; Akasaka R; Matsumoto T; Otsuka K; Nishizuka SS
    PLoS One; 2016; 11(1):e0146275. PubMed ID: 26727500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer.
    Beránek M; Sirák I; Vošmik M; Petera J; Drastíková M; Palička V
    Acta Medica (Hradec Kralove); 2016; 59(2):54-8. PubMed ID: 27526306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases.
    Chen ZG; Ji XM; Xu YX; Fong WP; Liu XY; Liang JY; Tan Q; Wen L; Cai YY; Wang DS; Li YH
    Ther Adv Med Oncol; 2024; 16():17588359241230752. PubMed ID: 38425989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct circulating tumor DNA detection from unpurified plasma using a digital PCR platform.
    Sefrioui D; Beaussire L; Perdrix A; Clatot F; Michel P; Frebourg T; Di Fiore F; Sarafan-Vasseur N
    Clin Biochem; 2017 Nov; 50(16-17):963-966. PubMed ID: 28645720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.
    Postel M; Roosen A; Laurent-Puig P; Taly V; Wang-Renault SF
    Expert Rev Mol Diagn; 2018 Jan; 18(1):7-17. PubMed ID: 29115895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Barault L; Amatu A; Siravegna G; Ponzetti A; Moran S; Cassingena A; Mussolin B; Falcomatà C; Binder AM; Cristiano C; Oddo D; Guarrera S; Cancelliere C; Bustreo S; Bencardino K; Maden S; Vanzati A; Zavattari P; Matullo G; Truini M; Grady WM; Racca P; Michels KB; Siena S; Esteller M; Bardelli A; Sartore-Bianchi A; Di Nicolantonio F
    Gut; 2018 Nov; 67(11):1995-2005. PubMed ID: 28982739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Tumor-Specific Mutated and Methylated DNA in Colorectal Cancer.
    Thomsen CB; Andersen RF; Lindebjerg J; Hansen TF; Jensen LH; Jakobsen A
    JCO Precis Oncol; 2019 Dec; 3():1-8. PubMed ID: 35100675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients.
    Olmedillas López S; García-Olmo DC; García-Arranz M; Guadalajara H; Pastor C; García-Olmo D
    Int J Mol Sci; 2016 Apr; 17(4):484. PubMed ID: 27043547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.
    Rasmussen SL; Krarup HB; Sunesen KG; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    Colorectal Dis; 2016 Jun; 18(6):549-61. PubMed ID: 26998585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.
    Thierry AR; Mouliere F; Gongora C; Ollier J; Robert B; Ychou M; Del Rio M; Molina F
    Nucleic Acids Res; 2010 Oct; 38(18):6159-75. PubMed ID: 20494973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.